These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. Aoyama Y; Nagai M; Kitajima Y Br J Dermatol; 2010 May; 162(5):1049-55. PubMed ID: 20222919 [TBL] [Abstract][Full Text] [Related]
27. IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse. Nomura H; Wada N; Takahashi H; Kase Y; Yamagami J; Egami S; Iriki H; Mukai M; Kamata A; Ito H; Fujii H; Ishikura T; Koseki H; Watanabe T; Yamada T; Ohara O; Koyasu S; Amagai M J Immunol; 2022 Feb; 208(3):582-593. PubMed ID: 34996836 [TBL] [Abstract][Full Text] [Related]
28. Dsg2 Upregulation as a Rescue Mechanism in Pemphigus. Sigmund AM; Steinert LS; Egu DT; Bayerbach FC; Waschke J; Vielmuth F Front Immunol; 2020; 11():581370. PubMed ID: 33193387 [TBL] [Abstract][Full Text] [Related]
29. Role of PKC and ERK Signaling in Epidermal Blistering and Desmosome Regulation in Pemphigus. Egu DT; Kugelmann D; Waschke J Front Immunol; 2019; 10():2883. PubMed ID: 31867019 [TBL] [Abstract][Full Text] [Related]
30. The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting? Spindler V; Endlich A; Hartlieb E; Vielmuth F; Schmidt E; Waschke J Am J Pathol; 2011 Oct; 179(4):1905-16. PubMed ID: 21864491 [TBL] [Abstract][Full Text] [Related]
31. Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin. Ishii K; Yoshida K; Stanley JR; Yamagami J; Amagai M; Ishiko A J Invest Dermatol; 2020 Oct; 140(10):1919-1926.e7. PubMed ID: 32142800 [TBL] [Abstract][Full Text] [Related]
32. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. Calkins CC; Setzer SV; Jennings JM; Summers S; Tsunoda K; Amagai M; Kowalczyk AP J Biol Chem; 2006 Mar; 281(11):7623-34. PubMed ID: 16377623 [TBL] [Abstract][Full Text] [Related]
33. Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris. Huang Y; Jedličková H; Cai Y; Rehman A; Gammon L; Ahmad US; Uttagomol J; Parkinson EK; Fortune F; Wan H Front Immunol; 2021; 12():649502. PubMed ID: 33968042 [No Abstract] [Full Text] [Related]
34. Standardized Production of Anti-Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research. Mueller EJ; Rahimi S; Sauta P; Shojaeian T; Durrer L; Quinche S; Francois M; Locher E; Edler M; Illi M; Gentinetta T; Lau K; Pojer F; Borradori L; Hariton WVJ Curr Protoc; 2024 Aug; 4(8):e1118. PubMed ID: 39169810 [TBL] [Abstract][Full Text] [Related]
35. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390 [TBL] [Abstract][Full Text] [Related]
37. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis. Femiano F Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959 [TBL] [Abstract][Full Text] [Related]
38. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213 [TBL] [Abstract][Full Text] [Related]
39. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]